期刊文献+

法舒地尔阻断Rho/ROCK通路对胶质瘤细胞生长的影响 被引量:1

Rho/ROCK inhibitor, fasudil, suppresses glioma cell line SHG-44 progression in vitro
原文传递
导出
摘要 目的观察Rho/ROCK信号转导通路抑制剂法舒地尔对人脑胶质瘤细胞株SHG44增殖、迁移及凋亡方面的影响并探讨其机制。方法使用不同浓度(10、20、40、80、160μmol/L)的法舒地尔干预SHG4d细胞,作用不同时间,相差显微镜下观察细胞形态变化;噻唑蓝(MTT)比色法检测16、24、48h细胞增殖;伤痕愈合实验检测细胞迁移能力;Westernblot法检测ROCK—1蛋白表达;流式细胞仪检测24h细胞凋亡。结果随着法舒地尔干预浓度增加,ROCK-I蛋白表达逐渐下降(P〈0.05);MTT法显示法舒地尔对SHG44细胞增殖的抑制作用有明显的浓度依赖性及时间依赖性(P〈0.05);伤痕愈合实验显示较高浓度组(40、80、160μmol/L)与低浓度组(10、20μmol/L)、对照组比较,细胞迁移受到明显抑制(P〈0.05);流式细胞仪检测显示较高浓度组早期凋亡率高于对照组、低浓度组(P〈0.05)。结论法舒地尔可能通过抑制ROCK的活性及诱导凋亡来抑制人脑胶质瘤细胞株SHG-44的增殖、迁移等恶性生物学行为。 Objective To observe the anti-tumor effects of Rho/ROCK inhibitor, fasudil, on pro- liferation, migration and apoptosis of the human glioma cell line SHG-44, furthermore exploring the possi- ble mechanism. Methods SHG-44 cells were treated with various concentrations ( 10, 20, 40, 80 and 160 mxmol/L) of fasudil for different durations respectively. Morphological changes of SHG-44 cells were observed under a convered phase microscope. The inhibitory rate of cell proliferation was detected by meth- yl thiazol tetrazolium (MTT) assay, and 50% inhibition concentration was calculated. The migratory abili- ty was evaluated by using wound healing assay. Apoptosis rate was assessed by flow cytometry (FCM). The expression level of ROCK-I protein was detected by using Western blotting. Results Fasudil inhibited SHG-44 cell proliferation and migration, and induced cell apoptosis in a time- and concentration-dependent manner. There was significant difference between higher-concentration groups (40, 80, and 160μmol/L) and lower-concentration groups ( 10, and 20 μmol/L) or control group ( P 〈 0. 05 ). The expression of ROCK-I was remarkably lower in higher-concentration group than in control group or lower-concentration group at the same time points (P 〈 0. 05 ). Conclusion Fasudil may suppress the progression of SHG-44 in vitro by inhibiting ROCK-1 and inducing apoptosis of tumor ceils.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第9期1671-1673,共3页 Chinese Journal of Experimental Surgery
基金 山西省卫生厅科技攻关计划资助项目(20100224)
关键词 胶质瘤 法舒地尔 Rho/ROCK信号转导通路 增殖 Glioma Fasudil Rho/ROCK signaling pathway Proliferation
  • 相关文献

参考文献13

  • 1Rattan R,Giri S.Singh AK, et al. Rho/ROCK pathway as a target of tumor therapy. J Neurosci Res,2006,83:243-255.
  • 2刘鹏,向健威,潘力,马廉亭.经椎动脉内持续注射盐酸法舒地尔治疗脑血管痉挛[J].中华实验外科杂志,2011,28(4):582-585. 被引量:4
  • 3肖卫东,喻爱喜,陈娟.Rho激酶在体外神经元缺氧及再灌注损伤中的作用[J].中华实验外科杂志,2009,26(8):1062-1064. 被引量:3
  • 4Aspenstrom P. The Rho GTPases have multiple effects on the actin ey- toskeleton. Exp Cell Res, 1999,246 : 20-25.
  • 5Fukata M,Nakagawa M,Kaibuehi K. Rules of Rho-family GTPases in cell polarisation and dircetional nligration. CmT Opiu Cell Biol,2003, 15:590-597.
  • 6Salhia B,Rntten F, Nakada M, el al. Inhibition of Rbo-kinase affects astrocytoma morphology, motility, and invasion through activation of Rael ,Cancer Res ,2005,65:8792-8800.
  • 7Fu XD, Giretti MS, Baldacci C, et al. Extra-nuclear signaling of pro- gesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton. PLuS One,2008,3 :e2790.
  • 8Gadea G, de Toledo M, Anguille C, et al. Loss of p53 promotes RhoA- ROCK-dependent cell migration and invasion in 3D matrices. J Cell Bio1,2007 ,178 :23-30.
  • 9Abraham MT, Kuriakose MA, Sacks PG, et al. Motility-related proteins as markers tbr head and neck squamuus cell eaneer, l,aryngoseope, 2001.111,1285-1289.
  • 10刘娜,毕锋,潘阳林,薛妍,张星,时永全,张宇梅,杜静平,樊代明.RhoA在胃癌细胞中的表达及其作用[J].中华肿瘤杂志,2004,26(1):26-29. 被引量:23

二级参考文献35

  • 1惠品晶,陆士奇,冀勇,王中,刘春风,惠国桢.兔蛛网膜下腔出血后脑血管痉挛的血流动力学变化[J].中华实验外科杂志,2005,22(9):1142-1142. 被引量:7
  • 2李俊,贺道华,秦尚振,马廉亭,张小征.鞘内注射罂粟碱对脑血管痉挛的治疗作用[J].中华实验外科杂志,2005,22(12):1528-1529. 被引量:7
  • 3叶伟,王晓峰,赵春波,刘波.蛛网膜下腔出血后脑血管痉挛的发生机制研究进展[J].中华实验外科杂志,2006,23(1):124-126. 被引量:12
  • 4卢建 余应年 等.G蛋白及其偶联受体介导的跨膜信号转导.受体、信号传导系统与疾病[M].济南:山东科学技术出版社,1998.174-182.
  • 5Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl JMed,2006,355:928-939.
  • 6A1-Yamany M ,Wallace MC. Management of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Intensive Care Med, 1999,25 : 1463-1466.
  • 7Sen J, Belli A,Albon H, et al. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol, 2003,2 : 614- 621.
  • 8Porchet F, Chiolero R, de Tribolet N. Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage. Acta Neurochir ( Wien), 1995,137:62-69.
  • 9Stiefel MF, Heuer GG, Abrahams JM, et al. The effect of nimodipine on cerebral oxygenation in patients with poor-grade subarachnoid hemorrhage. J Neurosurg,2004,101 :594-599.
  • 10Subramani K, Ghrew M. Severe myocardial depression following intravenous nimodipine for aneurysmal subarachnoid haemorrhage. Intensive Care Med ,200d- ,30 : 1498-1499.

共引文献35

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部